GSK

Key TakeawaysHIV epidemic prevention efforts are being strengthened as ViiV Healthcare triples its supply of long-acting cabotegravir for PrEP to low- and middle-income...

Key TakeawaysGSK’s Menveo (MenACWY) receives a positive opinion for a fully liquid, single-vial presentation from the EMA. If approved, this version will simplify...

Key TakeawaysThe next round is expected to target COPD drugs like GSK's Breo Ellipta and Trelegy Ellipta. ICER is preparing a special report...

Key TakeawaysBlenrep (belantamab mafodotin) combinations for relapsed/refractory multiple myeloma have been accepted for regulatory review by Japan’s Ministry of Health, Labour and Welfare...

Key TakeawaysChina sees around 30,000 new cases of multiple myeloma each year, with the disease’s incidence and mortality rates rising significantly over the...

Key TakeawaysThe phase III trial, MATINEE, showed that adding Nucala (mepolizumab) to standard inhaled maintenance therapy significantly reduced moderate and severe exacerbations in...

Key Takeaways:The European Commission has authorized GSK's Arexvy for adults aged 50-59 at increased risk of severe RSV disease. Approximately 20 million adults...

Key Takeaways:Nucala is now approved in Japan as the first biologic with a four-weekly dosing regimen for CRSwNP, offering an alternative to surgery...

Lung cancer remains one of the most pressing health challenges globally, with small-cell lung cancer (SCLC) representing approximately 15% of all lung cancer cases...

Ranitidine was at the center of the litigation case brought against GSK in the Florida State Court, as the plaintiff alleged that the medication...

Endometrial cancer treatment has reached a new milestone with AstraZeneca's recent approval of a combination therapy involving its PD-L1 inhibitor, Imfinzi (durvalumab), and its...

GSK has announced a significant legal victory in the ongoing Zantac litigation on caused colorectal cancer. On August 6, 2024, the jury in the...

GSK Singapore has secured approval from the Singapore Health Sciences Authority (HSA) for Jemperli (dostarlimab) to be used in combination with chemotherapy for advanced...

As sales of COVID-19 vaccines continue to decline, lawsuits associated with these products are on the rise. In the latest legal action, the University...

Chemotherapy combined with immunotherapy receives expanded the US Food and Drug Administration (FDA) approval for endometrial cancer treatment and GSK has announced the FDA...